drug · antibody
astegolimab
Phase 3updated 3mo agoby F. Hoffmann-La Roche Ltd🔗 ChEMBL
Phase 3community read0 votes
Antibody drug with a maximum clinical stage of Phase 3 (across all indications), with 5 investigational indications.
targets
IL-33 receptor (ST2)
all catalysts(0)
nothing on the calendar yet
Trials studying astegolimab
- phase3A Study to Evaluate the Long-Term Safety of Astegolimab in Participants With Chronic Obstructive Pulmonary Disease (COPD)
- phase3A Study to Evaluate Astegolimab in Participants With Chronic Obstructive Pulmonary Disease
- phase2A Study to Evaluate the Efficacy and Safety of Astegolimab in Participants With Chronic Obstructive Pulmonary Disease
- phase1A Study to Evaluate the Effect of Injection Site on PK of Astegolimab in Healthy Subjects
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 38m ago
Found something off?
comments(0)
5-min edit window · permanent after that